Clinical Trial Update: Study of Atezolizumab as Monotherapy and in Combination With Platinum-Based Chemotherapy in Participants With Untreated Locally Advanced or Metastatic Urothelial Carcinoma [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating atezolizumab as a standalone therapy and in combination with platinum-based chemotherapy for untreated locally advanced or metastatic u…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Urothelial Carcinoma

Drugs mentioned

• Tecentriq (atezolizumab)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Urothelial Carcinoma | Phase 3 | Status: COMPLETED | Results posted: 2023-12-13